Literature DB >> 29875149

YAP and TAZ are essential for basal and squamous cell carcinoma initiation.

Maud Debaugnies1, Adriana Sánchez-Danés1, Sandrine Rorive2, Maylis Raphaël1, Mélanie Liagre1, Marie-Astrid Parent1, Audrey Brisebarre1, Isabelle Salmon2, Cédric Blanpain3,4.   

Abstract

YAP and TAZ are key downstream regulators of the Hippo pathway, regulating cell proliferation and differentiation. YAP and TAZ activation has been reported in different cancer types. However, it remains unclear whether they are required for the initiation of major skin malignancies like basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Here, we analyze the expression of YAP and TAZ in these skin cancers and evaluate cancer initiation in knockout mouse models. We show that YAP and TAZ are nuclear and highly expressed in different BCC types in both human and mice. Further, we find that cells with nuclear YAP and TAZ localize to the invasive front in well-differentiated SCC, whereas nuclear YAP is homogeneously expressed in spindle cell carcinoma undergoing EMT We also show that mouse BCC and SCC are enriched for YAP gene signatures. Finally, we find that the conditional deletion of YAP and TAZ in mouse models of BCC and SCC prevents tumor formation. Thus, YAP and TAZ are key determinants of skin cancer initiation, suggesting that targeting the YAP and TAZ signaling pathway might be beneficial for the treatment of skin cancers.
© 2018 The Authors.

Entities:  

Keywords:  TAZ; YAP; basal cell carcinoma; cancer; squamous cell carcinoma

Mesh:

Substances:

Year:  2018        PMID: 29875149      PMCID: PMC6030692          DOI: 10.15252/embr.201845809

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  63 in total

1.  Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches.

Authors:  Shelby C Peterson; Markus Eberl; Alicia N Vagnozzi; Abdelmadjid Belkadi; Natalia A Veniaminova; Monique E Verhaegen; Christopher K Bichakjian; Nicole L Ward; Andrzej A Dlugosz; Sunny Y Wong
Journal:  Cell Stem Cell       Date:  2015-04-02       Impact factor: 24.633

Review 2.  YAP and WWTR1: New targets for skin cancer treatment.

Authors:  Thomas Andl; Linli Zhou; Kun Yang; Ana Luisa Kadekaro; Yuhang Zhang
Journal:  Cancer Lett       Date:  2017-03-07       Impact factor: 8.679

3.  Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

Authors:  J Jonkers; R Meuwissen; H van der Gulden; H Peterse; M van der Valk; A Berns
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

4.  Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin.

Authors:  Haiying Zhang; H Amalia Pasolli; Elaine Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

5.  Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.

Authors:  David W Ellison; James Dalton; Mehmet Kocak; Sarah Leigh Nicholson; Charles Fraga; Geoff Neale; Anna M Kenney; Dan J Brat; Arie Perry; William H Yong; Roger E Taylor; Simon Bailey; Steven C Clifford; Richard J Gilbertson
Journal:  Acta Neuropathol       Date:  2011-01-26       Impact factor: 17.088

6.  Transduction of mechanical and cytoskeletal cues by YAP and TAZ.

Authors:  Georg Halder; Sirio Dupont; Stefano Piccolo
Journal:  Nat Rev Mol Cell Biol       Date:  2012-08-16       Impact factor: 94.444

7.  Sox9 Controls Self-Renewal of Oncogene Targeted Cells and Links Tumor Initiation and Invasion.

Authors:  Jean-Christophe Larsimont; Khalil Kass Youssef; Adriana Sánchez-Danés; Vijayakumar Sukumaran; Matthieu Defrance; Benjamin Delatte; Mélanie Liagre; Pieter Baatsen; Jean-Christophe Marine; Saskia Lippens; Christopher Guerin; Véronique Del Marmol; Jean-Marie Vanderwinden; Francois Fuks; Cédric Blanpain
Journal:  Cell Stem Cell       Date:  2015-06-18       Impact factor: 24.633

8.  The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin.

Authors:  V Vasioukhin; L Degenstein; B Wise; E Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

9.  YAP1 increases organ size and expands undifferentiated progenitor cells.

Authors:  Fernando D Camargo; Sumita Gokhale; Jonathan B Johnnidis; Dongdong Fu; George W Bell; Rudolf Jaenisch; Thijn R Brummelkamp
Journal:  Curr Biol       Date:  2007-11-01       Impact factor: 10.834

10.  The Hedgehog receptor Patched controls lymphoid lineage commitment.

Authors:  Anja Uhmann; Kai Dittmann; Frauke Nitzki; Ralf Dressel; Milena Koleva; Anke Frommhold; Arne Zibat; Claudia Binder; Ibrahim Adham; Mirko Nitsche; Tanja Heller; Victor Armstrong; Walter Schulz-Schaeffer; Jürgen Wienands; Heidi Hahn
Journal:  Blood       Date:  2007-05-29       Impact factor: 22.113

View more
  21 in total

Review 1.  Hip to the Game: YAP/TAZ is required for nonmelanoma skin cancers.

Authors:  Matilde M Miranda; William E Lowry
Journal:  EMBO J       Date:  2018-07-23       Impact factor: 11.598

2.  Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.

Authors:  Shigeki Sekine; Tohru Kiyono; Eijitsu Ryo; Reiko Ogawa; Susumu Wakai; Hitoshi Ichikawa; Koyu Suzuki; Satoru Arai; Koji Tsuta; Mitsuaki Ishida; Yuko Sasajima; Naoki Goshima; Naoya Yamazaki; Taisuke Mori
Journal:  J Clin Invest       Date:  2019-05-30       Impact factor: 14.808

3.  Increased ACTL6A occupancy within mSWI/SNF chromatin remodelers drives human squamous cell carcinoma.

Authors:  Chiung-Ying Chang; Zohar Shipony; Sherry G Lin; Ann Kuo; Xiaochen Xiong; Kyle M Loh; William J Greenleaf; Gerald R Crabtree
Journal:  Mol Cell       Date:  2021-10-22       Impact factor: 17.970

4.  THY1-mediated mechanisms converge to drive YAP activation in skin homeostasis and repair.

Authors:  Egor Sedov; Elle Koren; Sucheta Chopra; Roi Ankawa; Yahav Yosefzon; Marianna Yusupova; Lucien E Weiss; Adnan Mahly; Arad Soffer; Alona Feldman; Chen Luxenburg; Yoav Shechtman; Yaron Fuchs
Journal:  Nat Cell Biol       Date:  2022-07-07       Impact factor: 28.213

Review 5.  The deadly cross-talk between Hippo pathway and epithelial-mesenchymal transition (EMT) in cancer.

Authors:  Ioanna Akrida; Vasiliki Bravou; Helen Papadaki
Journal:  Mol Biol Rep       Date:  2022-05-23       Impact factor: 2.742

6.  TEAD1 and TEAD3 Play Redundant Roles in the Regulation of Human Epidermal Proliferation.

Authors:  Jingting Li; Manisha Tiwari; Xiaojun Xu; Yifang Chen; Pablo Tamayo; George L Sen
Journal:  J Invest Dermatol       Date:  2020-03-03       Impact factor: 8.551

7.  Aberrant epithelial polarity cues drive the development of precancerous airway lesions.

Authors:  Andrew Tilston-Lunel; Sarah Mazzilli; Nathan M Kingston; Aleksander D Szymaniak; Julia Hicks-Berthet; Joseph G Kern; Kristine Abo; Mary E Reid; Catalina Perdomo; Andrew A Wilson; Avrum Spira; Jennifer Beane; Xaralabos Varelas
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

8.  YAP drives cutaneous squamous cell carcinoma formation and progression.

Authors:  Zoé Vincent-Mistiaen; Ahmed Elbediwy; Hannah Vanyai; Jennifer Cotton; Gordon Stamp; Emma Nye; Bradley Spencer-Dene; Gareth J Thomas; Junhao Mao; Barry Thompson
Journal:  Elife       Date:  2018-09-20       Impact factor: 8.140

9.  Correlation between tripartite motif-containing protein 44 protein expression and the prognosis of postoperative patients exhibiting skin squamous cell carcinoma.

Authors:  Jian Wu; Nai-Zhou Guo; Lei-Lei Cui; Wei Wang; Cun-Quan Xiong; Xue-Yan Zhang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

10.  Cyclopeptide RA-V Inhibits Organ Enlargement and Tumorigenesis Induced by YAP Activation.

Authors:  Xinyan Ji; Lihua Song; Li Sheng; Anhui Gao; Yang Zhao; Shixun Han; Yuchao Zhang; Chu Zhu; Simeng Zhao; Zhe Wang; Bohan Xu; Li Li; Jia Li; Ninghua Tan; Bin Zhao
Journal:  Cancers (Basel)       Date:  2018-11-16       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.